Cargando…

mRNA vaccine development for cholangiocarcinoma: a precise pipeline

Cholangiocarcinoma (CHOL) is one of the most aggressive tumors worldwide and cannot be effectively treated by conventional and novel treatments, including immune checkpoint blockade therapy. The mRNA vaccine-based immunotherapeutic strategy has attracted much attention for various diseases, however,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Tian-Yu, Huang, Xing, Zhang, Gang, Lu, Ming-Hao, Liang, Ting-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277828/ https://www.ncbi.nlm.nih.gov/pubmed/35821067 http://dx.doi.org/10.1186/s40779-022-00399-8

Ejemplares similares

Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
por: Huang, Xing, et al.
Publicado: (2021)

Commentary of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)

Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
por: Huang, Xing, et al.
Publicado: (2022)

The dawn of mRNA vaccines: The COVID-19 case
por: Verbeke, Rein, et al.
Publicado: (2021)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
por: Brown, Ronald B.
Publicado: (2021)

Post-COVID mRNA-vaccine IgG4 shift: worrisome?
por: Kadkhoda, Kamran
Publicado: (2023)

mRNA vaccines in disease prevention and treatment
por: Zhang, Gang, et al.
Publicado: (2023)

Liposomes and mRNA: Two technologies together create a COVID-19 vaccine
por: Gregoriadis, Gregory
Publicado: (2021)

Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins
por: Weng, Yuhua, et al.
Publicado: (2021)

A quantitative systems pharmacology approach to support mRNA vaccine development and optimization
por: Selvaggio, Gianluca, et al.
Publicado: (2021)

A short discussion about the SARS-CoV-2 mRNA-1273 vaccine
por: Oronsky, Bryan, et al.
Publicado: (2021)

mRNA lipid nanoparticles induce immune tolerance to treat human diseases
por: Cao, Wei, et al.
Publicado: (2023)

Longevity regulation by NMD-mediated mRNA quality control
por: Son, Heehwa G., et al.
Publicado: (2017)

A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19 vaccine associated with muscle weakness
por: Kim, Chul Soo, et al.
Publicado: (2022)

Regulatory RNAs: Have mRNA Untranslated Regions Joined the Party
por: Hughes, Thomas A, et al.
Publicado: (2008)

A new function of glucocorticoid receptor: regulation of mRNA stability
por: Park, Ok Hyun, et al.
Publicado: (2015)

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development
por: Huang, Xing, et al.
Publicado: (2021)

Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines
por: Murphy, Kevin R., et al.
Publicado: (2021)

Potential prognosis index for m(6)A-related mRNA in cholangiocarcinoma
por: Zhu, Huaqiang, et al.
Publicado: (2022)

Integration analysis of miRNA–mRNA expression exploring their potential roles in intrahepatic cholangiocarcinoma
por: Liu, Liyan, et al.
Publicado: (2023)

Exaptive origins of regulated mRNA decay in eukaryotes
por: Hamid, Fursham M., et al.
Publicado: (2016)

Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer
por: Gui, Cheng-Peng, et al.
Publicado: (2022)

Micro (mRNA) molecules could pack a big punch in the fight against neuromuscular disease
por: Rybalka, Emma, et al.
Publicado: (2020)

An integrated mRNA–lncRNA signature for overall survival prediction in cholangiocarcinoma
por: Xu, Derong, et al.
Publicado: (2023)

Spermatogenesis Studies Reveal a Distinct Nonsense-Mediated mRNA Decay (NMD) Mechanism for mRNAs with Long 3′UTRs
por: Mühlemann, Oliver
Publicado: (2016)

DRUID: a pipeline for transcriptome-wide measurements of mRNA stability
por: Lugowski, Andrew, et al.
Publicado: (2018)

Research Advances on the Stability of mRNA Vaccines
por: Cheng, Feiran, et al.
Publicado: (2023)

p53-mediated control of gene expression via mRNA translation during Endoplasmic Reticulum stress
por: López, Ignacio, et al.
Publicado: (2015)

Designing m-Health interventions for precision mental health support
por: Bidargaddi, N., et al.
Publicado: (2020)

A universal pipeline for mobile mRNA detection and insights into heterografting advantages under chilling stress
por: Wang, Ying, et al.
Publicado: (2020)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Re-thinking miRNA-mRNA interactions: Intertwining issues confound target discovery
por: Cloonan, Nicole
Publicado: (2015)

Too Much Compromise in Today's CRISPR Pipelines
por: Fox, Richard
Publicado: (2019)

Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
por: Gadaleta-Caldarola, Gennaro, et al.
Publicado: (2022)

Recent transcriptome-wide mapping of UPF1 binding sites reveals evidence for its recruitment to mRNA before translation
por: Zünd, David, et al.
Publicado: (2013)

Correction to: A universal pipeline for mobile mRNA detection and insights into heterografting advantages under chilling stress
por: Wang, Ying, et al.
Publicado: (2020)

mRNA vaccines in the prevention and treatment of diseases
por: Gu, Yangzhuo, et al.
Publicado: (2022)

Improving the Pipeline for Developing and Testing Pharmacological Treatments in Pregnancy
por: Chappell, Lucy C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v1uedsfihrmmiucf1q0i63d6cs